Abstract 37: The Brain Care Score and Neuroimaging Markers in Asymptomatic Individuals in the UK Biobank
Cyprien Rivier,Sanjula D Singh,Jasper Senff,Sandro Marini,Tin Oreskovic,Sinclair Carr,Keren Papier,Megan Conroy,Zeina Chemali,Leidys Gutierrez,Akashleena Mallick,Livia Parodi,Ernst Mayerhofer,Christina Kourkoulis,Santiago Clocchiatti-Tuozzo,Courtney Nunley,Sam Payabvash,Amy Newhouse,An Ouyang,Ronald M Lazar,Michael B Westover,Aleksandra Pikula,Sarah Ibrahim,Bart Brouwers,Virginia J Howard,George Howard,Nirupama Yechoor,Cornelia van Duijn,Thomas Littlejohns,Rudolph Tanzi,Gregory Fricchione,Kevin N Sheth,Jonathan Rosand,Christopher D Anderson,Guido J Falcone
DOI: https://doi.org/10.1161/str.55.suppl_1.37
IF: 10.17
2024-02-01
Stroke
Abstract:The 21-point Brain Care Score (BCS) is a novel tool designed to motivate individuals and care providers to take action to reduce the risk of stroke and dementia by motivating lifestyle changes (Fig 1). In this study we aimed to assess if the BCS is also associated with brain changes on MRI in people who have not yet developed dementia or stroke. Methods: This study was conducted within the MRI substudy of the longitudinal cohort study UK Biobank. The assessed MRI neuroimaging markers included: brain volume, white matter hyperintensities (WMH) volume, fractional anisotropy (FA) and mean diffusivity (MD). FA/MD metrics were calculated as the average across 48 discrete brain regions. We used multivariable linear regression to test for association between the BCS computed using baseline data (2006-2010) and neuroimaging markers, measured both during first (2014+) and repeat (2019+) MRI assessments. Results: There were 34,772 study participants with MRIs and available BCS data (mean age 55, 53% female). Every five-point increase in the BCS was associated with an 11% increase in brain volume (Beta 0.11, SE 0.01), a 26% reduction in WMH volume (Beta -0.26, SE 0.01), a 13% increase in average FA (Beta 0.13, SE 0.02), and a 9% decrease in average MD (Beta -0.09, SE 0.01). There were 3,778 study participants with first and repeat MRI (mean age 53, 53% female). Comparing the first and repeat imaging assessments, every five-point increase in baseline BCS was associated with a slower growth in WMH volume (Beta -0.08, SE 0.03) and a slower reduction in average FA (Beta 0.11, SE 0.03). Discussion: Among middle-aged adults without dementia or stroke, a higher BCS is strongly associated with better neuroimaging brain health profiles and slower rates of brain health decline. Given that the neuroimaging markers evaluated in our study are recognized risk factors that precede stroke and dementia by many years, our results support the BCS is a promising tool for early intervention to prevent these conditions.
peripheral vascular disease,clinical neurology